ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers, 3 USDMF, 1 NDC API, $ API Reference Price

3 API Suppliers
3 USDMF
1 NDC API
$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

FINISHED DOSAGE FORMULATIONS

62 FDF Dossiers, 14 FDA Orange Book, 23 Europe, 11 Canada, 4 Australia, 10 South Africa

62 FDF Dossiers
14 FDA Orange Book
23 Europe
11 Canada
4 Australia
10 South Africa

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 12 SPI Pharma, 1 Pfanstiehl, 5 Actylis, 1 BASF, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 3 Kerry, 2 Microlex e.U, 2 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

relatedExcipients
1 Rochem International Inc
12 SPI Pharma
1 Pfanstiehl
5 Actylis
1 BASF
2 Gangwal Chemicals
1 Ingredion Pharma Solutions
3 Kerry
2 Microlex e.U
2 Pluviaendo
3 Roquette
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 10 Chewable & Orodispersible Aids, 10 Parenteral, 9 Direct Compression, 9 Taste Masking, 3 Granulation, 3 Co-Processed Excipients, 3 Disintegrants & Superdisintegrants, 1 Controlled & Modified Release, 1 Coating Systems & Additives, 1 Thickeners and Stabilizers, 1 API Stability Enhancers, 1 Film Formers & Plasticizers, 1 Topical

excipientsByApplications
17 Fillers, Diluents & Binders
10 Chewable & Orodispersible Aids
10 Parenteral
9 Direct Compression
9 Taste Masking
3 Granulation
3 Co-Processed Excipients
3 Disintegrants & Superdisintegrants
1 Controlled & Modified Release
1 Coating Systems & Additives
1 Thickeners and Stabilizers
1 API Stability Enhancers
1 Film Formers & Plasticizers
1 Topical

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 31 NEWS #PharmaBuzz

media
2 DATA COMPILATION #PharmaFlow
31 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 23 Finished Drug Prices, 4 Annual Reports

globalSalesInformation
4 US Medicaid Prescriptions
23 Finished Drug Prices
4 Annual Reports

MARKET PLACE

3 APIs, 1 FDF Dossiers

marketPlace
3 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

18 Health Canada Patents

patents
18 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM , 1 USP , 1 Others

otherSolutions
1 EDQM
1 USP
1 Others

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 63,712

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

9DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

2,147,483,647

Annual Reports (USD Million)

3,709

Finished Drug Prices

36 RELATED EXCIPIENT COMPANIES

70EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Dtxsid10151274

Molecular Formula

C₂₅₆H₃₈₇N₆₅O₇₉S₆

Molecular Weight

5832 g/mol

InChI Key

VOMXSOIBEJBQNF-UTTRGDHVSA-N

1 2D Structure

Insulin aspart

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(4S)-4-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2R)-2-[[(2R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]-3-sulfanylpropanoyl]amino]-3-sulfanylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-5-[[(2S)-4-amino-1-[[(2S)-1-[[(2R)-1-[[(1S)-3-amino-1-carboxy-3-oxopropyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-5-oxopentanoic acid;(4S)-4-[[2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-4-oxobutanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-3-sulfanylpropanoyl]amino]acetyl]amino]-5-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-1-oxohexan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid

2.1.2 InChI

InChI=1S/C157H232N40O44S2.C99H155N25O35S4/c1-77(2)54-102(180-130(214)84(15)172-135(219)101(48-51-123(210)211)179-152(236)126(82(11)12)194-149(233)105(57-80(7)8)183-145(229)111(64-93-68-165-76-171-93)188-151(235)114(72-198)175-121(207)71-169-133(217)115(73-242)191-140(224)103(55-78(3)4)181-144(228)110(63-92-67-164-75-170-92)187-137(221)100(46-49-117(160)203)178-146(230)112(65-118(161)204)189-153(237)125(81(9)10)193-131(215)96(159)58-87-30-21-18-22-31-87)139(223)184-108(61-90-38-42-94(201)43-39-90)142(226)182-104(56-79(5)6)148(232)195-127(83(13)14)154(238)192-116(74-243)134(218)168-69-119(205)173-99(47-50-122(208)209)136(220)176-97(37-29-53-166-157(162)163)132(216)167-70-120(206)174-106(59-88-32-23-19-24-33-88)141(225)185-107(60-89-34-25-20-26-35-89)143(227)186-109(62-91-40-44-95(202)45-41-91)150(234)196-128(85(16)199)155(239)190-113(66-124(212)213)147(231)177-98(36-27-28-52-158)138(222)197-129(86(17)200)156(240)241;1-12-46(9)77(121-73(134)36-100)97(156)122-76(45(7)8)95(154)108-56(25-29-75(137)138)80(139)105-54(23-27-70(102)131)83(142)117-66(40-161)93(152)119-68(42-163)94(153)124-79(48(11)127)98(157)116-64(38-126)90(149)123-78(47(10)13-2)96(155)120-67(41-162)92(151)115-63(37-125)89(148)110-58(31-44(5)6)85(144)111-59(32-49-14-18-51(128)19-15-49)86(145)106-53(22-26-69(101)130)81(140)109-57(30-43(3)4)84(143)107-55(24-28-74(135)136)82(141)113-61(34-71(103)132)88(147)112-60(33-50-16-20-52(129)21-17-50)87(146)118-65(39-160)91(150)114-62(99(158)159)35-72(104)133/h18-26,30-35,38-45,67-68,75-86,96-116,125-129,198-202,242-243H,27-29,36-37,46-66,69-74,158-159H2,1-17H3,(H2,160,203)(H2,161,204)(H,164,170)(H,165,171)(H,167,216)(H,168,218)(H,169,217)(H,172,219)(H,173,205)(H,174,206)(H,175,207)(H,176,220)(H,177,231)(H,178,230)(H,179,236)(H,180,214)(H,181,228)(H,182,226)(H,183,229)(H,184,223)(H,185,225)(H,186,227)(H,187,221)(H,188,235)(H,189,237)(H,190,239)(H,191,224)(H,192,238)(H,193,215)(H,194,233)(H,195,232)(H,196,234)(H,197,222)(H,208,209)(H,210,211)(H,212,213)(H,240,241)(H4,162,163,166);14-21,43-48,53-68,76-79,125-129,160-163H,12-13,22-42,100H2,1-11H3,(H2,101,130)(H2,102,131)(H2,103,132)(H2,104,133)(H,105,139)(H,106,145)(H,107,143)(H,108,154)(H,109,140)(H,110,148)(H,111,144)(H,112,147)(H,113,141)(H,114,150)(H,115,151)(H,116,157)(H,117,142)(H,118,146)(H,119,152)(H,120,155)(H,121,134)(H,122,156)(H,123,149)(H,124,153)(H,135,136)(H,137,138)(H,158,159)/t84-,85+,86+,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,125-,126-,127-,128-,129-;46-,47-,48+,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,76-,77-,78-,79-/m00/s1

2.1.3 InChI Key

VOMXSOIBEJBQNF-UTTRGDHVSA-N

2.1.4 Canonical SMILES

CCC(C)C(C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CS)C(=O)NC(CS)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)NC(C(C)CC)C(=O)NC(CS)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)N)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CS)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)CN.CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CS)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC5=CN=CN5)NC(=O)C(CO)NC(=O)CNC(=O)C(CS)NC(=O)C(CC(C)C)NC(=O)C(CC6=CN=CN6)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC7=CC=CC=C7)N

2.1.5 Isomeric SMILES

CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN.C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC6=CN=CN6)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC7=CC=CC=C7)N)O

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. Dtxsid10151274

2.3 Create Date

2007-07-03

3 Chemical and Physical Properties

Molecular Formula	C₂₅₆H₃₈₇N₆₅O₇₉S₆
Molecular Weight	5832 g/mol
Hydrogen Bond Donor Count	86
Hydrogen Bond Acceptor Count	91
Rotatable Bond Count	188
Exact Mass	5829.6654893 g/mol
Monoisotopic Mass	5827.6587796 g/mol
Topological Polar Surface Area	2350 Å²
Heavy Atom Count	406
Formal Charge	0
Complexity	13000
Isotope Atom Count	0
Defined Atom Stereocenter Count	52
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

4 Drug and Medication Information

4.1 Drug Information

1 of 2
Drug Name	Novolog
PubMed Health	Insulin Aspart Protamine/Insulin Aspart (Injection)
Drug Classes	Antidiabetic
Drug Label	NovoLog Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]) is a human insulin analog suspension containing 70% insulin aspart protamine crystals and 30% soluble insulin aspart. NovoLog Mix 70/30 is a b...
Active Ingredient	Insulin aspart recombinant
Dosage Form	Injectable
Route	Subcutaneous
Strength	1000 units/10ml (100 units/ml)
Market Status	Prescription
Company	Novo Nordisk

2 of 2
Drug Name	Novolog
PubMed Health	Insulin Aspart Protamine/Insulin Aspart (Injection)
Drug Classes	Antidiabetic
Drug Label	NovoLog Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]) is a human insulin analog suspension containing 70% insulin aspart protamine crystals and 30% soluble insulin aspart. NovoLog Mix 70/30 is a b...
Active Ingredient	Insulin aspart recombinant
Dosage Form	Injectable
Route	Subcutaneous
Strength	1000 units/10ml (100 units/ml)
Market Status	Prescription
Company	Novo Nordisk

API SUPPLIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

[{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1661193000,"product":"ANIA211201 RECOMBINANT INSULIN ASPART","address":"PLOT NO18 INTERNATIONAL BIOTECH,PA RK HINJAWADI PHASE II","city":"PUNE,MAHARASHTRA","supplier":"WUXI LIANYIN IMPORT-EXPORT TRADING CO., LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"BIOPHARM","customerCountry":"INDIA","quantity":"0.20","actualQuantity":"200.16","unit":"GMS","unitRateFc":"79.9","totalValueFC":"16187.6","currency":"USD","unitRateINR":"6434.9","date":"23-Aug-2022","totalValueINR":"1288000","totalValueInUsd":"16187.6","indian_port":"BOMBAY AIR","hs_no":"29371200","bill_no":"2129814","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"PLOT NO18 INTERNATIONAL BIOTECH,PA RK HINJAWADI PHASE II"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1672684200,"product":"INSULIN ASPART (R-DNA ORIGIN) BULK (FOC SHIPMENT) (01 GTC 12L WITH 01 LOGGER 350 USD ON RETURNABLE BASIS, VALUE FOR CUST","address":"BIOCON PARK, PLOT NO.2,3,4 AND 5,,","city":"BANGALORE,KARNATAKA","supplier":"BIOCON","supplierCountry":"MALAYSIA","foreign_port":"N\/A","customer":"BIOCON","customerCountry":"INDIA","quantity":"0.08","actualQuantity":"75","unit":"GMS","unitRateFc":"118","totalValueFC":"9043.8","currency":"USD","unitRateINR":"9858.9","date":"03-Jan-2023","totalValueINR":"739418","totalValueInUsd":"9043.8","indian_port":"Biocon-SEZ","hs_no":"29371200","bill_no":"1000084","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"MALAYSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"NO 1 JALAN BIOTEKNOLOGI 1 KAWASAN PERINDUSTRIAN SILC JOHOR MY 79200","customerAddress":"BIOCON PARK, PLOT NO.2,3,4 AND 5,,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1698604200,"product":"INSULIN ASPART PROCESS INTERMEDIATE","address":"BIOCON PARK, PLOT NO.2,3,4 AND 5,,","city":"BANGALORE,KARNATAKA","supplier":"BIOCON","supplierCountry":"MALAYSIA","foreign_port":"N\/A","customer":"BIOCON","customerCountry":"INDIA","quantity":"0.06","actualQuantity":"60","unit":"GMS","unitRateFc":"123","totalValueFC":"7463.6","currency":"USD","unitRateINR":"10356.6","date":"30-Oct-2023","totalValueINR":"621396","totalValueInUsd":"7463.6","indian_port":"Biocon-SEZ","hs_no":"29371200","bill_no":"1014833","productDescription":"Intermediate","marketType":"LESS REGULATED MARKET","country":"MALAYSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"NO.1,JALAN BIOTEKNOLOGI 1 KAWASAN PERINDUSTRIAN SILC JOHOR,79200, MALAYSIA MY","customerAddress":"BIOCON PARK, PLOT NO.2,3,4 AND 5,,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715538600,"product":"RECOMBINANT INSULIN ASPART ( SAMPLE FOR TESTING PURPOSE )","address":"301\/A, SHREYA HOUSE, PEREIRA HILL","city":"MUMBAI, MAHARASHTRA.","supplier":"DONGBAO IMPORT AND EXPORT TRADING (","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"BIOPHARM","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"55500","totalValueFC":"56373.7","currency":"USD","unitRateINR":"4681425","date":"13-May-2024","totalValueINR":"4681425","totalValueInUsd":"56373.7","indian_port":"Bombay Air","hs_no":"29371200","bill_no":"3453836","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"HAINAN) CO., LTDROOMS 30-246 ,5 THFLOOR , BUILDING A , ENTREPRENEURSHIPINCUBATION CENTER ,226 NANHAI AVE CHINA","customerAddress":"301\/A, SHREYA HOUSE, PEREIRA HILL"}]

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country	Total Quantity (KGS)	Average Price (USD/KGS)	Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Australia

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

South Africa

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

Chewable & Orodispersible Aids

Parenteral

Direct Compression

Taste Masking

Granulation

Co-Processed Excipients

Disintegrants & Superdisintegrants

Controlled & Modified Release

Coating Systems & Additives

Thickeners and Stabilizers

API Stability Enhancers

Film Formers & Plasticizers

Topical

Digital Content

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

NEWS #PharmaBuzz

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Finished Drug Prices

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Annual Reports

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

APIs

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF DOSSIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

Health Canada Patents

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

EDQM

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USP

Others

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Find Health Canada Patents Information with Patent Number, Filing Date and Patent Expiration Date of Insulin aspart on PharmaCompass.com

Insulin Aspart

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers

3 USDMF

1 NDC API

$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

FINISHED DOSAGE FORMULATIONS

62 FDF Dossiers

14 FDA Orange Book

23 Europe

11 Canada

4 Australia

10 South Africa

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

12 SPI Pharma

1 Pfanstiehl

5 Actylis

1 BASF

2 Gangwal Chemicals

1 Ingredion Pharma Solutions

3 Kerry

2 Microlex e.U

2 Pluviaendo

3 Roquette

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders

10 Chewable & Orodispersible Aids

10 Parenteral

9 Direct Compression

9 Taste Masking

3 Granulation

3 Co-Processed Excipients

3 Disintegrants & Superdisintegrants

1 Controlled & Modified Release

1 Coating Systems & Additives

1 Thickeners and Stabilizers

1 API Stability Enhancers

1 Film Formers & Plasticizers

1 Topical

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow

31 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions

23 Finished Drug Prices

4 Annual Reports

MARKET PLACE

3 APIs

1 FDF Dossiers

PATENTS & EXCLUSIVITIES

18 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM

1 USP

1 Others

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 63,712

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

9DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

36 RELATED EXCIPIENT COMPANIES

70EXCIPIENTS BY APPLICATIONS